Cargando…
Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review
The current standard of care for advanced non-small-cell lung cancer is based on detecting actionable mutations that can benefit from targeted therapy. Comprehensive genetic tests can have long turn-around times, and because EGFR mutations are the most prevalent actionable mutation, a quick detectio...
Autores principales: | Caputo, Alessandro, D’Ardia, Angela, Sabbatino, Francesco, Picariello, Caterina, Ciaparrone, Chiara, Zeppa, Pio, D’Antonio, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125729/ https://www.ncbi.nlm.nih.gov/pubmed/34063720 http://dx.doi.org/10.3390/ijms22094852 |
Ejemplares similares
-
Observations on hematogones with light chain restriction.
por: D'Ardia, Angela, et al.
Publicado: (2022) -
An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy
por: Cavallo, Monica, et al.
Publicado: (2023) -
Prostatic stromal sarcoma: Report of a rare case in a young male and review of the literature
por: Addesso, Maria, et al.
Publicado: (2023) -
Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples
por: Offerman, Saskia, et al.
Publicado: (2021) -
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test
por: De Luca, Caterina, et al.
Publicado: (2017)